Status:
COMPLETED
Therapeutic Effects Analysis of Pudendal Nerve Infiltrations After 3 Months, in Patients Suffering of Pudendal Neuralgia
Lead Sponsor:
Nantes University Hospital
Conditions:
Pudendal Neuralgia
Canal Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Pudendal neuralgia is a recent identified pathology, extremely invalidating, related to chronic pelvic entrapment. Nowadays, pudendal neuralgia can be treated with: * neuropathic pains treatment * sp...
Eligibility Criteria
Inclusion
- Patient presenting the four indispensable clinical criteria for pudendal neuralgia (Nantes' criteria)
- Man or woman aged more than 18 years old
- Suffering from pudendal neuralgia since more than six months
- Without previous infiltration identical to the one proposed by the protocol
- Without previous surgery of pudendal nerve
- Without any hemorrhagic risk factor
- No contra-indication to Lidocaïne, Depo-medrol or contrast-product injections
- Pain intensity with an average \> or = 40/100 (measured by scales during the fifteen days before infiltration)
Exclusion
- Patient presenting one of the four exclusion clinical criterium for pudendal neuralgia (Nantes' criteria)
- Patient who has filled his "pain note book" during less than 5 days over the 15 days before the infiltration
- Pregnancy
- Depression (Beck scale \> 16/39)
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT00851513
Start Date
November 1 2008
End Date
February 1 2011
Last Update
September 4 2013
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
CH de la Côte Basque
Bayonne, France, 64100
2
Centre MARIENIA
Cambo-les-Bains, France, 64250
3
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63058
4
Hospices Civils de Lyon
Lyon, France, 69495